Zonisamide in the treatment of binge eating disorder with obesity: A randomized controlled trial

Journal of Clinical Psychiatry

Volumn 67, Issue 12, 2006, Pages 1897-1906

  McElroy, Susan L ^a   Kotwal, Renu ^a   Guerdjikova, Anna I ^a   Welge, Jeffrey A ^a   Nelson, Erik B ^a   Lake, Kathleen A ^a   D'Alessio, David A ^a,b   Keck Jr , Paul E ^a,b   Hudson, James I ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; LEPTIN; PLACEBO; ZONISAMIDE;

ADULT; AMNESIA; ARTICLE; BACKACHE; BINGE EATING DISORDER; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FLATULENCE; FRACTURE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HORMONE BLOOD LEVEL; HUMAN; INCIDENCE; INSOMNIA; LIBIDO; MALE; NAUSEA; NERVOUSNESS; OBESITY; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; THINKING IMPAIRMENT; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINARY FREQUENCY; URTICARIA; XEROSTOMIA;

EID: 33846108312     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n1209     Document Type: Article

References (67)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
2. Walsh BT, ed. The Current Status of Binge Eating Disorder. Int J Eat Disord 2003;34(suppl):S1-S120
3. Streigel-Moore RH, Franko DL. Epidemiology of binge eating disorder. Int J Eat Disord 2003;34(suppl):S19-S29
4. Hudson JI, Hiripi E, Pope HG Jr, et al. Prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2006; epub ahead of print
5. Yanovski SZ, Nelson JE, Dubbert KB, et al. Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993;150:1472-1479
6. Peterson CB, Miller KB, Crow SJ, et al. Subtypes of binge eating disorder based on psychiatric history. Int J Eat Disord 2005;38:273-276
7. Bulik CM, Sullivan PF, Kendler KS. An empirical study of the classification of eating disorders. Am J Psychiatry 2000;157:886-895
8. Yanovski SZ. Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic? Int J Eat Disord 2003;34(suppl):S117-S120
9. Johnson JG, Spitzer RL, Williams JBW. Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients. Psychol Med 2001;31:1455-1466
10. Bulik CM, Reichborn-Kjennerud T. Medical morbidity in binge eating disorder. Int J Eat Disord 2003;34(suppl):S39-S46
11. Rieger E, Wilfley DE, Stein RI, et al. A comparison of quality of life in obese individuals with and without binge eating disorder. Int J Eat Disord 2005;37:234-240
12. Dymek-Valentine M, Rienecke-Hoste R, Alverdy J. Assessment of binge eating disorder in morbidly obese patients evaluated for gastric bypass: SCID versus QEWP-R. Eat Weight Disord 2004;9:211-216
13. Busetto L, Segato G, De Luca M, et al. Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding. Obes Surg 2005;15:195-201
14. Hudson JI, Lalonde JK, Berry JM, et al. Binge eating disorder as a distinct familial phenotype in obese individuals. Arch Gen Psychiatry 2006;63:313-319
15. Hellstrom PM, Geliebter A, Naslund E, et al. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br J Nutr 2004;92(suppl 1):S47-S57
16. Potoczna N, Branson R, Kral JG, et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment of severe obesity. J Gastrointest Surg 2004;8:971-981
17. Geliebter A, Gluck ME, Hashim SA. Plasma ghrelin concentrations are lower in binge-eating disorder. J Nutr 2005;135:1326-1330
18. Wilfley DE, Welch RR, Stein RI, et al. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 2002;59:713-721
19. Wonderlich SA, deZwaan M, Mitchell JE, et al. Psychological and dietary treatments of binge eating disorder: conceptual implications. Int J Eat Disord 2003;34(suppl):S58-S73
20. Carter WP, Hudson JI, Lalonde JK, et al. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 2003;34(suppl):S74-S88
21. Appolinario JC, McElroy SL. Pharmacologic approaches in the treatment of binge eating disorder. Curr Drug Targets 2004;5:301-307
22. Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. Biol Psychiatry 2005;57:301-309
23. Devlin MJ, Goldfein JA, Petkova E, et al. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obes Res 2005;13:1077-1088
24. Grilo CM, Masheb RM. A randomized controlled comparison of guided self-help cognitive behavioral therapy and behavioral weight loss for binge eating disorder. Behav Res Ther 2005;43:1509-1525
25. National Institute for Clinical Excellence. Eating Disorders-Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa, Related Eating Disorders. NICE Clinical Guideline No. 9. London, England: National Institute for Clinical Excellence; 2004
26. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998;155:1756-1762
27. McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000;157:1004-1006
28. Arnold LM, McElroy SL, Hudson JI, et al. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 2002;63:1028-1033
29. McElroy SL, Hudson JI, Malhotra S, et al. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiatry 2003;64:807-813
30. Grilo CM, Masheb RM, Salant SL. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder, a randomized, double-blind, placebo-controlled trial. Biol Psychiatry 2005;57:1193-1201
31. Appolinario JC, Bacaltchuk J, Sichieri R, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 2003;60:1109-1116
32. Milano W, Petrella C, Casella A, et al. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. Adv Ther 2005;22:25-31
33. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:255-261
34. McElroy SL, Hudson JI, Capece JA, et al. Topiramate for the treatment of moderate to severe binge eating disorder associated with obesity: a double-blind, placebo-controlled study. Presented at the American College of Neuropsychopharmacology annual meeting; Dec 3-7, 2005; Hollywood, Fla
35. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-546
36. McElroy SL, Shapira NA, Arnold LM, et al. Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 2004;65:1463-1469
37. McElroy SL, Kotwal R, Hudson JI, et al. Zonisamide in the treatment of binge eating disorder: an open-label, prospective trial. J Clin Psychiatry 2004;65:50-56
38. Oommen KJ, Mathew SS. Zonisamide: a new antiepileptic drug. Clin Neuropharmacol 1999;22:192-200
39. Faught E, Ayala R, Montouris GG, et al. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-1779
40. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2005;4:CD001416
41. Gadde KM, Franciscy DM, Wagner II HR, et al. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA 2003;289:1820-1825
42. Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature 2000;404:661-671
43. Stanley BG, Willett III VL, Donias HW, et al. Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control. Am J Physiol 1996;270:R443-R449
44. Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;22:193-205
45. Okada M, Hirano T, Kawata Y, et al. Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res 1999;34:187-197
46. Okada M, Kawata Y, Mizuno K, et al. Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode. Br J Pharmacol 1998;124:1277-1285
47. Ueda Y, Doi T, Tokumaru J, et al. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. Brain Res Mol Brain Res 2003;116:1-6
48. Hudson JI, Pope HG Jr. Affective spectrum disorders: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990;147:552-564
49. McElroy SL, Suppes T, Keck PE Jr, et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry 2005;66:617-624
50. Anand A, Bukhari L, Jennings SA, et al. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients. J Clin Psychiatry 2005;66:195-198
51. Pi-Sunyer FX. NHLBI Obesity Education Initiative Expert Panel on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998;6(suppl 2):51S-209S
52. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I disorders. Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 2002
53. Guy W. ECDEU Assessment Manual for Psychophaimacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976;218-222
54. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 2: validity. Arch Gen Psychiatry 1989;46:1012-1016
55. Stunkard AJ, Messick S. Eating Inventory Manual. San Antonio, Tex: The Psychological Corporation, Harcourt Brace & Company; 1988
56. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
57. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons; 2004
58. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993;50:739-750
59. Mallinckrodt CH, Sanger TM, Dube S, et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry 2003;53:754-760
60. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-1630
61. Macdonald RL. Zonisamide: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, et al. eds. Antiepileptic Drugs. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002;867-872
62. Winum J-Y, Scozzafava A, Montero J-L, et al. Sulfamates and their therapeutic potential. Med Res Rev 2005;25:186-228
63. Grilo CM, Masheb RM, Wilson GT. Different methods for assessing the features of eating disorders in patients with binge eating disorder: a replication. Obes Res 2001;9:418-422
64. Saunders R. "Grazing": a high risk behavior. Obes Surg 2004;14:98-102
65. Masheb RM, Grilo CM. Emotional overeating and its associations with eating disorder psychopathology among overweight patients with binge eating disorder. Int J Eat Disord 2006;39:141-146
66. Grilo CM, Masheb RM. Night-time eating in men and women with binge eating disorder. Behav Res Ther 2004;42:397-407
67. le Grange D, Gorin A, Catley D, et al. Does momentary assessment detect binge eating in overweight women that is denied at interview? Eur Eat Disord Rev 2001;9:309-324